Valuation (29%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -0.98 | N/A |
PEG Ratio (TTM) | 0.35 | N/A |
P/S Ratio (TTM) | 22.89 | N/A |
P/B Ratio (TTM) | 1.85 | N/A |
P/FCF Ratio (TTM) | -1.24 | N/A |
Price to 5YR AVG Earnings Ratio | N/A | N/A |
Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -130.42% | N/A |
ROE (TTM) | -118.90% | N/A |
Net Profit Margin (TTM) | -2,344.64% | N/A |
ROIC 5YR AVG | N/A | N/A |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -4.12% | -219.45% | N/A |
Revenue | -25.00% | N/A | N/A |
Net Income | -4.52% | -370.91% | N/A |
Cash Flow | -3.74% | -339.84% | N/A |
Health (39%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 3.39 | N/A |
Quick Ratio (TTM) | 3.39 | N/A |
D/E Ratio (TTM) | 0.04 | N/A |
Interest Coverage (TTM) | -154.41 | N/A |
Piotroski F-Score | 2 | N/A |
Altman Z-Score | N/A | N/A |
LTL to 5YR AVG FCF | N/A | N/A |
Shares Outstanding Growth 5YR AVG | N/A | N/A |